人骨髓间充质干细胞移植的双人源化小鼠中HBV感染诱导肝硬化发生
本研究旨在建立HBV感染诱导慢性肝炎和肝硬化的小鼠模型。将人骨髓间充质干细胞(hBMSC)移植入暴发性肝衰竭的FRGS小鼠,构建肝与免疫细胞双人源化(hBMSC-FRGS)小鼠。hBMSC-FRGS小鼠在HBV感染后54周以55%的频率进展为慢性肝炎和肝硬化。
要点
- hBMSC移植可挽救暴发性肝衰竭小鼠并重建人源肝细胞和多种免疫细胞。
- hBMSC-FRGS小鼠在HBV感染后出现持续病毒血症及特异性免疫炎症反应。
- HBV感染后54周,55%的hBMSC-FRGS小鼠进展为慢性肝炎和肝硬化。
核心结论
- 该新型人源化小鼠模型再现了人HBV感染诱导的肝硬化,为研究病毒免疫病理生理学和体内测试抗病毒治疗提供了研究机会。
研究设计与样本
- 将人骨髓间充质干细胞(hBMSC)移植入经仓鼠抗小鼠CD95抗体JO2诱导暴发性肝衰竭的Fah-/-Rag2-/-IL-2Rγc-/- SCID(FRGS)小鼠,构建肝和免疫细胞双人源化(hBMSC-FRGS)小鼠。
- 对生成的hBMSC-FRGS小鼠评估持续病毒血症、特异性免疫和炎症反应及肝脏病理生理损伤,以表征HBV感染后慢性肝炎和肝硬化的进展。
主要发现
- hBMSC植入挽救了暴发性肝衰竭小鼠,表现为功能性人肝细胞强劲增殖和转分化,以及包括B细胞、T细胞、自然杀伤细胞、树突状细胞和巨噬细胞在内的多种免疫细胞谱系。
- HBV感染后,hBMSC-FRGS小鼠出现持续病毒血症和特异性免疫及炎症反应,并在54周后以55%的频率进展为慢性肝炎和肝硬化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Developing a small animal model that accurately delineates the natural history of hepatitis B virus (HBV) infection and immunopathophysiology is necessary to clarify the mechanisms of host-virus interactions and to identify intervention strategies for HBV-related liver diseases. This study aimed to develop an HBV-induced chronic hepatitis and cirrhosis mouse model through transplantation of human bone marrow mesenchymal stem cells (hBMSCs). DESIGN: Transplantation of hBMSCs into Fah-/-Rag2-/-IL-2Rγc-/- SCID (FRGS) mice with fulminant hepatic failure (FHF) induced by hamster-anti-mouse CD95 antibody JO2 generated a liver and immune cell dual-humanised (hBMSC-FRGS) mouse. The generated hBMSC-FRGS mice were subjected to assessments of sustained viremia, specific immune and inflammatory responses and liver pathophysiological injury to characterise the progression of chronic hepatitis and cirrhosis after HBV infection. RESULTS: The implantation of hBMSCs rescued FHF mice, as demonstrated by robust proliferation and transdifferentiation of functional human hepatocytes and multiple immune cell lineages, including B cells, T cells, natural killer cells, dendritic cells and macrophages. After HBV infection, the hBMSC-FRGS mice developed sustained viremia and specific immune and inflammatory responses and showed progression to chronic hepatitis and liver cirrhosis at a frequency of 55% after 54 weeks. CONCLUSION: This new humanised mouse model recapitulates the liver cirrhosis induced by human HBV infection, thus providing research opportunities for understanding viral immune pathophysiology and testing antiviral therapies in vivo.
引用
- Yuan L, Jiang J, Liu X, et al. HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation. Gut. 2019. PMID: 30700543. doi:10.1136/gutjnl-2018-316091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。